NASDAQ Biotechnology Index
Перейти к навигации
Перейти к поиску
| NASDAQ Biotechnology Ind | |
|---|---|
| Статус | Рассчитывается |
| Биржи | NASDAQ |
| Компоненты | 122 (на данный момент) |
| Веб-сайт | NASDAQ Biotechnology Index Официальная страница индекса |
NASDAQ Biotechnology Index — американский фондовый индекс. Индекс составляют биотехнологические и фармацевтические компании, чьи акции торгуются на бирже NASDAQ.
Критерии[править | править код]
Критерии включения в NASDAQ Biotechnology Index:
- Компания должна иметь листинг на бирже NASDAQ.
- Компания должна относиться либо к биотехнологической, либо к фармацевтической отрасли.
- Компания не должна быть в процессе банкротства.
- Рыночная капитализация не менее $200 млн.
- Средний ежедневный объём торгов — 100 тысяч акций.
- Акции компании должны котироваться на биржах не менее 6 месяцев
Компоненты[править | править код]
В индекс входят следующие компании:
- Acorda Therapeutics Inc. (NASDAQ: ACOR)
- Adolor Corporation (NASDAQ: ADLR)
- Affymetrix Inc. (NASDAQ: AFFX)
- Akorn Inc. (NASDAQ: AKRX)
- Albany Molecular Research Inc. (NASDAQ: AMRI)
- Alexion Pharmaceuticals Inc. (NASDAQ: ALXN)
- Alexza Pharmaceuticals Inc. (NASDAQ: ALXA)
- Alkermes Inc. (NASDAQ: ALKS)
- Allos Therapeutics Inc. (NASDAQ: ALTH)
- Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY)
- AMAG Pharmaceuticals Inc. (NASDAQ: AMAG)
- Amgen Inc. (NASDAQ: AMGN)
- Amylin Pharmaceuticals Inc. (NASDAQ: AMLN)
- Arena Pharmaceuticals Inc. (NASDAQ: ARNA)
- ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA)
- ArQule Inc. (NASDAQ: ARQL)
- Array BioPharma Inc. (NASDAQ: ARRY)
- Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL)
- BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX)
- Biodel Inc. (NASDAQ: BIOD)
- Biogen Idec Inc. (NASDAQ: BIIB)
- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)
- BioMimetic Therapeutics Inc. (NASDAQ: BMTI)
- BMP Sunstone Corporation (NASDAQ: BJGP)
- Cadence Pharmaceuticals Inc. (NASDAQ: CADX)
- Cardiome Pharma Corporation (NASDAQ: CRME)
- Celera Corporation (NASDAQ: CRA)
- Celgene Corporation (NASDAQ: CELG)
- Cephalon Inc. (NASDAQ: CEPH)
- Columbia Laboratories Inc. (NASDAQ: CBRX)
- Crucell NV (NASDAQ: CRXL)
- Cubist Pharmaceuticals Inc. (NASDAQ: CBST)
- Cypress Bioscience Inc. (NASDAQ: CYPB)
- Cytokinetics Incorporated (NASDAQ: CYTK)
- Dendreon Corporation (NASDAQ: DNDN)
- DepoMed Inc. (NASDAQ: DEPO)
- Discovery Laboratories Inc. (NASDAQ: DSCO)
- Durect Corporation (NASDAQ: DRRX)
- Dyax Corporation (NASDAQ: DYAX)
- Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP)
- Enzon Pharmaceuticals Inc. (NASDAQ: ENZN)
- Exelixis Inc. (NASDAQ: EXEL)
- Facet Biotech Corporation (NASDAQ: FACT)
- Flamel Technologies S.A. (NASDAQ: FLML)
- Gen-Probe Incorporated (NASDAQ: GPRO)
- Genomic Health Inc. (NASDAQ: GHDX)
- Genzyme Corporation (NASDAQ: GENZ)
- Geron Corporation (NASDAQ: GERN)
- Gilead Sciences Inc. (NASDAQ: GILD)
- GTx Inc. (NASDAQ: GTXI)
- Halozyme Therapeutics Inc. (NASDAQ: HALO)
- Human Genome Sciences Inc. (NASDAQ: HGSI)
- Idenix Pharmaceuticals Inc. (NASDAQ: IDIX)
- Illumina Inc. (NASDAQ: ILMN)
- ImmunoGen Inc. (NASDAQ: IMGN)
- Immunomedics Inc. (NASDAQ: IMMU)
- Impax Laboratories Inc. (NASDAQ: IPXL)
- Incyte Corporation (NASDAQ: INCY)
- Inspire Pharmaceuticals Inc. (NASDAQ: ISPH)
- InterMune Inc. (NASDAQ: ITMN)
- Isis Pharmaceuticals Inc. (NASDAQ: ISIS)
- Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX)
- Life Technologies Corporation (NASDAQ: LIFE)
- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)
- Luminex Corporation (NASDAQ: LMNX)
- MannKind Corporation (NASDAQ: MNKD)
- Matrixx Initiatives Inc. (NASDAQ: MTXX)
- Maxygen Inc. (NASDAQ: MAXY)
- Medarex Inc. (NASDAQ: MEDX)
- Medivation Inc. (NASDAQ: MDVN)
- Micromet Inc. (NASDAQ: MITI)
- MiddleBrook Pharmaceuticals Inc. (NASDAQ: MBRK)
- Momenta Pharmaceuticals Inc. (NASDAQ: MNTA)
- Mylan Inc. (NASDAQ: MYL)
- Myriad Genetics Inc. (NASDAQ: MYGN)
- Nabi Biopharmaceuticals (NASDAQ: NABI)
- Nektar Therapeutics (NASDAQ: NKTR)
- Neurocrine Biosciences Inc. (NASDAQ: NBIX)
- Novavax Inc. (NASDAQ: NVAX)
- Noven Pharmaceuticals Inc. (NASDAQ: NOVN)
- NPS Pharmaceuticals Inc. (NASDAQ: NPSP)
- Obagi Medical Products Inc. (NASDAQ: OMPI)
- ONYX Pharmaceuticals Inc. (NASDAQ: ONXX)
- Optimer Pharmaceuticals Inc. (NASDAQ: OPTR)
- Orexigen Therapeutics Inc. (NASDAQ: OREX)
- OSI Pharmaceuticals Inc. (NASDAQ: OSIP)
- Osiris Therapeutics Inc. (NASDAQ: OSIR)
- Pain Therapeutics (NASDAQ: PTIE)
- PDL BioPharma Inc. (NASDAQ: PDLI)
- Perrigo Company (NASDAQ: PRGO)
- Pharmasset Inc. (NASDAQ: VRUS)
- Pozen Inc. (NASDAQ: POZN)
- Progenics Pharmaceuticals Inc. (NASDAQ: PGNX)
- Qiagen N.V. (NASDAQ: QGEN)
- QLT Inc. (NASDAQ: QLTI)
- Questcor Pharmaceuticals Inc. (NASDAQ: QCOR)
- Regeneron Pharmaceuticals Inc. (NASDAQ: REGN)
- Rigel Pharmaceuticals Inc. (NASDAQ: RIGL)
- Salix Pharmaceuticals Ltd. (NASDAQ: SLXP)
- Sangamo BioSciences Inc. (NASDAQ: SGMO)
- Santarus Inc. (NASDAQ: SNTS)
- Savient Pharmaceuticals Inc (NASDAQ: SVNT)
- Seagen Inc. (NASDAQ: SGEN)
- Sepracor Inc (NASDAQ: SEPR)
- Sequenom Inc. (NASDAQ: SQNM)
- Shire plc (NASDAQ: SHPGY)
- StemCells Inc. (NASDAQ: STEM)
- SuperGen Inc. (NASDAQ: SUPG)
- Synta Pharmaceuticals Corp. (NASDAQ: SNTA)
- Techne Corporation (NASDAQ: TECH)
- Teva Pharmaceutical Industries Limited (NASDAQ: TEVA)
- The Medicines Company (NASDAQ: MDCO)
- Theravance Inc. (NASDAQ: THRX)
- United Therapeutics Corporation (NASDAQ: UTHR)
- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)
- ViroPharma Incorporated (NASDAQ: VPHM)
- Vivus Inc. (NASDAQ: VVUS)
- Warner Chilcott Limited (NASDAQ: WCRX)
- XenoPort Inc. (NASDAQ: XNPT)
- XOMA Ltd. (NASDAQ: XOMA)
- ZymoGenetics Inc. (NASDAQ: ZGEN)